REQUEST A DEMO
Total
USD $0.00
Search more companies

Implameq S.A.S (Colombia)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Medical Equipment and Supplies Manufacturing | Other Ambulatory Health Care Services | Electronic and Precision Equipment Repair and Maintenance
Full name: Implameq S.A.S Profile Updated: September 10, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Implameq S.A.S is based in Colombia. The head office is in Cali. It operates in the Pharmacies and Drug Stores industry. It was incorporated on April 10, 2012. The total number of employees is currently 125 (2024). In its most recent financial highlights, the company reported a net sales revenue increase of 49.53% in 2023. Its’ total assets recorded a growth of 25.6%. The net profit margin of Implameq S.A.S decreased by 0.82% in 2023.

Headquarters
Cl 5 B2 # 30 - 14
Cali; Valle del Cauca;

Contact Details: Purchase the Implameq S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Implameq S.A.S report to view the information.
Outstanding Shares:
Purchase the Implameq S.A.S report to view the information.
Incorporation Date:
April 10, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Implameq S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
49.53%
Total operating revenue
46.2%
Operating profit (EBIT)
81.37%
EBITDA
77.41%
Net Profit (Loss) for the Period
25.15%
Total assets
25.6%
Total equity
48.54%
Operating Profit Margin (ROS)
1.56%
Net Profit Margin
-0.82%
Return on Equity (ROE)
-1.46%
Debt to Equity Ratio
-16.01%
Quick Ratio
-1.9%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?